Report of foreign issuer [Rules 13a-16 and 15d-16]

OPERATING SEGMENTS

v3.25.2
OPERATING SEGMENTS
 6 Months Ended
Jun. 30, 2025
Disclosure of operating segments [abstract]  
OPERATING SEGMENTS [Text Block]
NOTE 7 -
OPERATING SEGMENTS
 
General information:
 
Since inception date, the operation of the Group has been conducted through one operating segment, (i.e., sales of medical cannabis products and other products) to customers through certain geographical areas (i.e. Israel and Germany).

 

 
Six months ended June 30, 2025
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
                         
Revenue
  
$
10,689
    
$
14,507
    
$
-
    
$
25,196
  
                                 
Segment profit
  
$
738
    
$
612
    
$
-
    
$
1,350
  
                                 
Unallocated corporate expenses
                  
$
(1,542
)
  
$
(1,542
)
                                 
Total operating loss
                          
$
(192
)
                                 
Depreciation and amortization
  
$
862
    
$
72
    
$
-
    
$
934
  
 
 
Six months ended June 30, 2024:
 
   
Israel
    
Germany
    
Adjustments
    
Total
  
                         
Revenue
  
$
22,153
    
$
4,660
    
$
-
    
$
26,813
  
                                 
Segment profit (loss)
  
$
(7,332
)
  
$
351
    
$
-
    
$
(6,981
)
                                 
Unallocated corporate expenses
                  
$
(1,518
)
  
$
(1,518
)
                                 
Total operating loss
                          
$
(8,499
)
                                 
Depreciation and amortization
  
$
1,118
    
$
73
    
$
-
    
$
1,191